Joseph Capper News Today

Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 -- Anika Therapeutics, Inc. , a global joint...

By Dean Seal MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesnt meet regulatory requirements for a certain classification sought by the...

FDA tells MiMedx that its wound-healing product must be regulated as a biologic

MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus its resources on its Wound & Surgical business, driving profitability and 

By Stephen Nakrosis MiMedx Group said on Tuesday it will focus on accelerating growth of its wound and surgical business in a move it expects will improve...

First Quarter Net Sales of $71.7 Million Reflect an Increase of 21.7% Over the Prior Year Period Revenue Growth & Cost Controls Help Drive Improvements in Net Loss, EBITDA & Adjusted EBITDA1 ... | May 2, 2023

MiMedx (Nasdaq:MDXG) today announced it appointed Joseph Capper as CEO and director, effective immediately.

December 18, 2020 // By Nick Flaherty Philips says it is to merge with leading US-based home heart monitoring firm BioTelemetry in a €2.3bn cash deal. The all-cash deal with BioTelemetry (Malvern, PA) will boost Philips’ home monitoring Connected Care division and brings a US clinical trials division. The deal also brings a US cloud patient monitoring system at a time when the handling of patient data will be a key issue between the US and Europe. BioTelemetry ha...